Back
Duff & Phelps Utility and Infrastructure Fund Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
79
DPG
Duff & Phelps Utility and Infrastructure Fund
Last Price:
$12.67
Seasonality Move:
-1.06%
Sell
43
CRSP
CRISPR Therapeutics AG
Last Price:
$57.90
Seasonality Move:
14.46%
Buy
79
Duff & Phelps Utility and Infrastructure Fund (DPG)
is a Buy
Is Duff & Phelps Utility and Infrastructure Fund a Buy, Sell or Hold?
-
The current Duff & Phelps Utility and Infrastructure Fund [DPG] share price is $12.66. The Score for DPG is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
-
DPG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $55.86. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DPG Stock Price Chart
What is Duff & Phelps Utility and Infrastructure Fund's stock price today?
-
The Duff & Phelps Utility and Infrastructure Fund share price today is $12.66Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DPG is experiencing selling pressure, which indicates risk of future bearish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $55.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.
DPG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 41.53 | Sell |
| Chaikin Money Flow: | -69826 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.65 - 13.09) | Sell |
| Bollinger Bands (100): | (12.58 - 13.1) | Sell |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 49.16 | Sell |
| Chaikin Money Flow: | 78181 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.94 - 57.06) | Buy |
| Bollinger Bands (100): | (52.44 - 65.4) | Sell |
DPG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.61 | Buy |
| 20-day SMA: | 12.81 | Sell |
| 50-day SMA: | 12.99 | Sell |
| 200-day SMA: | 12.49 | Buy |
| 8-day EMA: | 12.66 | Sell |
| 20-day EMA: | 12.77 | Sell |
| 50-day EMA: | 12.86 | Sell |
| 200-day EMA: | 12.49 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.25 | Sell |
| 20-day SMA: | 55.05 | Buy |
| 50-day SMA: | 58.96 | Sell |
| 200-day SMA: | 51.1 | Buy |
| 8-day EMA: | 55.79 | Buy |
| 20-day EMA: | 55.79 | Buy |
| 50-day EMA: | 56.36 | Sell |
| 200-day EMA: | 37.56 | Buy |
Duff & Phelps Utility and Infrastructure Fund Earnings Growth & DPG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
Duff & Phelps Utility and Infrastructure Fund Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||